Literature DB >> 9119626

The status of health technology assessment worldwide. Results of an international survey.

S Perry1, E Gardner, M Thamer.   

Abstract

Health technology assessment (HTA) has increasingly become a valuable tool to examine effectiveness, quality of care, patient outcomes, and cost-effectiveness of health care technologies. In 1994 and 1995, a survey was conducted to document the scope of worldwide HTA activities; 103 organizations from 24 countries responded. This paper summarizes the results of this international survey, including a description of each country's program, types of technologies assessed, methodologies used, and dissemination approaches. Results for Canada, the United States, and European and other countries are presented separately.

Entities:  

Mesh:

Year:  1997        PMID: 9119626     DOI: 10.1017/s0266462300010254

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

1.  Health technology assessment in Canada and the United States: the case of biologics.

Authors:  J Scott Haas; Eric J Moskowitz
Journal:  Biotechnol Healthc       Date:  2007-04

2.  Health technology assessment of medical devices: a survey of non-European union agencies.

Authors:  Oriana Ciani; Britni Wilcher; Carl Rudolf Blankart; Maximilian Hatz; Valentina Prevolnik Rupel; Renata Slabe Erker; Yauheniya Varabyova; Rod S Taylor
Journal:  Int J Technol Assess Health Care       Date:  2015-06-05       Impact factor: 2.188

3.  Do ethical considerations influence any in HTA reports? A review of reports.

Authors:  Alireza Shams Moattar; Fariba Asghari; Reza Majdzadeh
Journal:  Med J Islam Repub Iran       Date:  2016-05-03

4.  Management of Medical Technology under the New Medical Policy Background in China.

Authors:  Suo-Wei Wu; Tong Chen; Ming Wu; Qi Pan; Yong Xuan; Liang-Yu Wei; Qin Wang; Chao Li; Jing-Chen Song
Journal:  Chin Med J (Engl)       Date:  2016-11-20       Impact factor: 2.628

5.  Evidence-based decision-making for diagnostic and therapeutic methods: the changing landscape of assessment approaches in Germany.

Authors:  Britta Olberg; Sabine Fuchs; Katja Matthias; Alexandra Nolting; Matthias Perleth; Reinhard Busse
Journal:  Health Res Policy Syst       Date:  2017-10-17

6.  Evidence-informed health policy 2 - survey of organizations that support the use of research evidence.

Authors:  John N Lavis; Elizabeth J Paulsen; Andrew D Oxman; Ray Moynihan
Journal:  Implement Sci       Date:  2008-12-17       Impact factor: 7.327

7.  Evidence-informed health policy 3 - interviews with the directors of organizations that support the use of research evidence.

Authors:  John N Lavis; Andrew D Oxman; Ray Moynihan; Elizabeth J Paulsen
Journal:  Implement Sci       Date:  2008-12-17       Impact factor: 7.327

8.  Editorial: Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies.

Authors:  Mihajlo Jakovljevic; Tetsuji Yamada
Journal:  Front Pharmacol       Date:  2017-09-21       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.